From the Sector

Reset
2 results
(c) FET
FET meltspinning system for biomedical applications
15.09.2021

FET: Further Gains in the Biomedical sector

Fibre Extrusion Technology of Leeds, UK has delivered nine meltspinning systems to clients in the biomedical sector since the onset of the Covid-19 pandemic, with a similar number currently on order for 2021/22. This way FET could confirm the position as an acknowledged world leader in meltspinning equipment for the production of precursor materials used in medical devices and as a default supplier for absorbable suture production systems, with orders virtually doubling year on year.

Recent installations include a multi-functional system that can produce both multifilament and monofilament pre-cursor fibres, but nonwoven systems have been particularly prominent, driven by the burgeoning demand for FFP3 masks, gowns and other medical products required during the pandemic. These have been sold to medical device manufacturing companies across the globe, including the Far East, USA and Europe. Research organisations have also invested in FET systems for biomedical applications, the most recent being the University of Leeds in a laboratory scale Spunbond system.

Fibre Extrusion Technology of Leeds, UK has delivered nine meltspinning systems to clients in the biomedical sector since the onset of the Covid-19 pandemic, with a similar number currently on order for 2021/22. This way FET could confirm the position as an acknowledged world leader in meltspinning equipment for the production of precursor materials used in medical devices and as a default supplier for absorbable suture production systems, with orders virtually doubling year on year.

Recent installations include a multi-functional system that can produce both multifilament and monofilament pre-cursor fibres, but nonwoven systems have been particularly prominent, driven by the burgeoning demand for FFP3 masks, gowns and other medical products required during the pandemic. These have been sold to medical device manufacturing companies across the globe, including the Far East, USA and Europe. Research organisations have also invested in FET systems for biomedical applications, the most recent being the University of Leeds in a laboratory scale Spunbond system.

The FET in-house Process Development Laboratory and ongoing collaboration with biomaterial polymer suppliers has helped to optimise the biomedical melt spinning technology. The Laboratory is at the disposal of customers for all aspects of confidential testing and evaluation. To further increase this competitive edge, FET will be opening a new Process Development Laboratory and Visitor Centre in early 2022.

More information:
meltspinning FET
Source:

Projectmarketing for FET

(c) Fibre Extrusion Technology
04.08.2021

New FET meltspinning system upgrade for NIRI

Fibre Extrusion Technology Ltd of Leeds, UK has installed a new meltspinning system to upgrade research facilities at NIRI, the Nonwovens Innovation & Research Institute Ltd UK, a global leader in nonwoven engineering and product development.

Established in 1998, FET is a leading supplier of laboratory and pilot meltspinning systems with installations in over 35 countries and has now successfully processed almost 30 different polymer types in multifilament, monofilament and nonwoven formats.
 
The installation comprises a FET-102 Series Laboratory Meltblown Spinning System and FET-103 Monofilament Meltspinning System. This advanced equipment enhances NIRI’s extensive pilot facilities and state-of-the-art analytical laboratory for fast tracking innovation. In particular, the FET meltblown system will be utilised for R&D, pilot projects, sampling and prototyping, proof of concept testing and for designing cost-effective, sustainable and innovative products.

Fibre Extrusion Technology Ltd of Leeds, UK has installed a new meltspinning system to upgrade research facilities at NIRI, the Nonwovens Innovation & Research Institute Ltd UK, a global leader in nonwoven engineering and product development.

Established in 1998, FET is a leading supplier of laboratory and pilot meltspinning systems with installations in over 35 countries and has now successfully processed almost 30 different polymer types in multifilament, monofilament and nonwoven formats.
 
The installation comprises a FET-102 Series Laboratory Meltblown Spinning System and FET-103 Monofilament Meltspinning System. This advanced equipment enhances NIRI’s extensive pilot facilities and state-of-the-art analytical laboratory for fast tracking innovation. In particular, the FET meltblown system will be utilised for R&D, pilot projects, sampling and prototyping, proof of concept testing and for designing cost-effective, sustainable and innovative products.

NIRI supports global manufacturing companies to identify new opportunities for meltblown nonwovens, develop their next generation of products and accelerate their commercialisation activities. NIRI’s new upgraded laboratory and pilot system from FET can process a wide range of polymer types, including chemically recycled polymers, bio-polymers and many difficult-to-process materials.

Source:

Project Marketing for Fibre Extrusion Technology